Author: Das, Undurti N.
Title: Can Bioactive Lipid Arachidonic Acid Prevent and Ameliorate COVID-19? Cord-id: uesry4z7 Document date: 2020_8_19
ID: uesry4z7
Snippet: It is proposed that the bioactive lipid, arachidonic acid (AA, 20:4 n-6), can inactivate severe acute respiratory syndrome(SARS-CoV-2), facilitate M1 and M2 macrophage generation, suppress inflammation, prevent vascular endothelial cell damage, and regulate inflammation resolution processes based on the timely formation of prostaglandin E2 (PGE2) and lipoxin A4 (LXA4) based on the context. Thus, AA may be useful both to prevent and manage coronavrus disease-2019(COVID-19).
Document: It is proposed that the bioactive lipid, arachidonic acid (AA, 20:4 n-6), can inactivate severe acute respiratory syndrome(SARS-CoV-2), facilitate M1 and M2 macrophage generation, suppress inflammation, prevent vascular endothelial cell damage, and regulate inflammation resolution processes based on the timely formation of prostaglandin E2 (PGE2) and lipoxin A4 (LXA4) based on the context. Thus, AA may be useful both to prevent and manage coronavrus disease-2019(COVID-19).
Search related documents:
Co phrase search for related documents- aa administration and acute respiratory syndrome: 1
- aa arachidonic acid and aa deficiency: 1, 2
- aa arachidonic acid and aa similar: 1
- aa arachidonic acid and acute respiratory distress syndrome: 1
- aa arachidonic acid and acute respiratory syndrome: 1, 2, 3, 4
- aa arachidonic acid and adipose tissue: 1
- aa arachidonic acid and liver failure: 1
- aa arachidonic acid and lox lipoxygenase: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date